SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 731.11 |
| Enterprise Value ($M) | 598.92 |
| Book Value ($M) | 120.26 |
| Book Value / Share | 1.42 |
| Price / Book | 6.08 |
| NCAV ($M) | 120.26 |
| NCAV / Share | 1.42 |
| Price / NCAV | 6.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.36 |
| Return on Assets (ROA) | -0.29 |
| Return on Equity (ROE) | -0.32 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.86 |
| Current Ratio | 8.86 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 135.57 |
| Assets | 135.57 |
| Liabilities | 15.30 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -50.59 |
| Net Income | -43.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -30.81 |
| Cash from Investing | 0.00 |
| Cash from Financing | 11.97 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 5.31 | 5.22 | |
| 13G/A | BlackRock, Inc. | 8.10 | 19.59 | |
| 13G/A | State Street Corp | 4.44 | -37.33 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 209,151 | 831,300 | 25.16 | |
| 537,800 | 1,559,964 | 34.48 | |
| 397,276 | 1,366,843 | 29.07 | |
| 299,819 | 929,113 | 32.27 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATHA – Athira Pharma, Inc. | ATRA – Atara Biotherapeutics, Inc. |
| AVIR – Atea Pharmaceuticals, Inc. | BBIO – BridgeBio Pharma, Inc. |
| BCRX – BioCryst Pharmaceuticals, Inc. |